Sign in to fuzzto save your conversations, follow your research and come back anytime.
Tatva Chintan Pharma
SectorChemicals
| Metric (₹ crore) | Q1 FY21 | Q2 FY21 | Q3 FY21 | Q4 FY21 | Q1 FY22 | Q2 FY22 | Q3 FY22 | Q4 FY22 | Q1 FY23 | Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 51.53 | 60.04 | 80.12 | 108.67 | 106.83 | 123.62 | 104.67 | 98.53 | 88.4 | 90.09 | 120.61 | 124.51 | 114.36 | 96.67 | 84.21 | 98.27 | 105.46 | 83.49 | 85.9 | 107.86 | 116.86 | 123.52 | 131.33 | 134.14 | 167.06 |
| Expenses | 41.19 | 53.68 | 55.6 | 84.2 | 81 | 88.16 | 80.7 | 76.54 | 73.19 | 78.91 | 102.69 | 108.23 | 93.02 | 76.42 | 73.21 | 82.66 | 92.85 | 77.9 | 78.84 | 98.91 | 99.53 | 101.3 | 105.85 | 106.02 | 134.76 |
| EBITDA | 10.34 | 6.36 | 24.52 | 24.47 | 25.83 | 35.46 | 23.97 | 21.99 | 15.21 | 11.18 | 17.92 | 16.28 | 21.34 | 20.25 | 11 | 15.61 | 12.61 | 5.59 | 7.06 | 8.95 | 17.33 | 22.22 | 25.48 | 28.12 | 32.3 |
| Depreciation | 1.68 | 1.68 | 1.59 | 1.78 | 1.9 | 2.06 | 2.08 | 2.15 | 2.33 | 2.31 | 2.38 | 2.53 | 6.01 | 6.78 | 6.58 | 6.23 | 6.67 | 6.81 | 6.92 | 7.26 | 8.97 | 9.05 | 9.07 | 9.76 | 10.57 |
| EBIT | 8.66 | 4.68 | 22.93 | 22.69 | 23.93 | 33.4 | 21.89 | 19.84 | 12.88 | 8.87 | 15.54 | 13.75 | 15.33 | 13.47 | 4.42 | 9.38 | 5.94 | -1.22 | 0.14 | 1.69 | 8.36 | 13.17 | 16.41 | 18.36 | 21.73 |
| Interest | 0.5 | 0.99 | 1.11 | 1.05 | 1.44 | 1.22 | 0.99 | 1.18 | 1.06 | 1.36 | 2.38 | 3.2 | 2.93 | 3.01 | 0.38 | 0.21 | 0.31 | 0.17 | 0.42 | 0.39 | 0.41 | 0.51 | 0.49 | 1.44 | 2.08 |
| Profit Before Tax | 8.16 | 3.69 | 21.82 | 21.64 | 22.49 | 32.18 | 20.9 | 18.66 | 11.82 | 7.51 | 13.16 | 10.55 | 12.4 | 10.46 | 4.04 | 9.17 | 5.63 | -1.39 | -0.28 | 1.3 | 7.95 | 12.66 | 15.92 | 16.92 | 19.65 |
| Net Profit | 6.71 | 3.56 | 20.88 | 21.12 | 23.15 | 32.41 | 22.81 | 17.51 | 9.8 | 7.11 | 11.62 | 16.95 | 9.5 | 7.78 | 3.46 | 9.61 | 5.21 | -0.66 | 0.14 | 1.03 | 6.65 | 9.92 | 15.17 | 10.32 | 15.98 |
| EPS | 3.34 | 1.77 | 10.39 | 10.51 | 11.52 | 15.02 | 10.29 | 7.9 | 4.42 | 3.21 | 5.24 | 7.65 | 4.29 | 3.43 | 1.48 | 4.11 | 2.23 | -0.29 | 0.06 | 0.44 | 2.84 | 4.24 | 6.49 | 4.41 | 6.83 |
| Metric (₹ crore) | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 12.59 | 7.36 | 25.31 | 19.69 | 20.38 | 27.78 | 98.04 | 24.77 | 31.49 |
| Investing Cash Flow | -30.17 | -16.77 | -40.18 | -20.66 | -196.81 | -101.23 | -120.62 | -65.3 | -116.03 |
| Financing Cash Flow | 7.34 | 17.4 | 9.95 | -4.71 | 234.96 | 37.8 | 30.52 | 16.59 | 78.93 |
| Net Cash Flow | -10.24 | 7.99 | -4.92 | -5.68 | 58.53 | -35.65 | 7.94 | -23.94 | -5.61 |
| Metric (₹ crore) | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 0 | 79.7 | 117.69 | 165.96 | 473.09 | 514.79 | 737.08 | 738.82 | 781.76 |
| Total Liabilities | 0 | 107.81 | 131.24 | 148.84 | 185.21 | 244.07 | 81.64 | 97.42 | 221.94 |
| Total Assets | 0 | 187.51 | 248.94 | 314.8 | 658.3 | 758.86 | 818.72 | 836.25 | 1,003.69 |